Investor List:

Top Drug Delivery Series A Investors in Boston / New England (19)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
KK
Kelvin Keh
Covalent Ventures·Managing Partner
Sweet spot: $2.0M
Range: $500K - $4.0M
Investors in Thailand, Investors in Indonesia, Investors in Boston (MA), Investors in San Francisco (CA), Investors in Singapore, Investors in Sydney (Australia), Investors in Melbourne (Australia), Investors in New Zealand
Investors in Food and Beverage (Series A), Investors in Impact (Series A), Investors in Medical Devices (Series A), Investors in Diverse Investors (Other Lists), Investors in Health IT (Series A), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Food and Beverage (Series A), Investors in Impact (Series A), Investors in Health IT (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Digital Health (Series A), Investors in Drug Delivery (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Digital Health (Series A)
to see your intro paths to Kelvin
Photo of Peter Parker, Managing Partner at Mission BioCapital
Peter Parker
Mission BioCapital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
to see your intro paths to Peter
Photo of Samir Mitragotri, Venture Partner at Catalio Capital
Samir Mitragotri
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Santa Barbara (CA), Investors in Boston (MA), Investors in Cambridge (MA)
to see your intro paths to Samir
Photo of C. Giovanni Traverso, Venture Partner at Catalio Capital
C. Giovanni Traverso
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA)
to see your intro paths to C. Giovanni
Photo of Jeffrey Karp, Venture Partner at Catalio Capital
Jeffrey Karp
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Jeffrey
Photo of Justin Hanes, Venture Partner at Catalio Capital
Justin Hanes
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Waltham (MA), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
to see your intro paths to Justin
Photo of Nathan Stebbins, Principal at Flagship Pioneering
Nathan Stebbins
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
to see your intro paths to Nathan
Photo of Sabrina Yang, Senior Associate at Flagship Pioneering
Sabrina Yang
Flagship Pioneering·Senior Associate
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A)
to see your intro paths to Sabrina
Get new data & insights delivered to your inbox
Firms investing in this space